In US market
Natco Pharma announced that its marketing partner Alvogen has received the final approval and is the first to market the generic equivalent to Oseltamivir phosphate, 6 mg/ ml powder for oral suspension in the United States. In December 2016, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
